ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 100 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,837,000 | +0.6% | 39,928 | -3.0% | 0.01% | 0.0% |
| Q3 2018 | $1,826,000 | +12.1% | 41,157 | -1.0% | 0.01% | +25.0% |
| Q2 2018 | $1,629,000 | +564.9% | 41,561 | +1126.0% | 0.00% | +300.0% |
| Q1 2018 | $245,000 | -44.6% | 3,390 | -90.4% | 0.00% | 0.0% |
| Q4 2016 | $442,000 | -9.6% | 35,280 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $489,000 | +40.1% | 35,280 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $349,000 | -41.5% | 35,280 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $597,000 | -23.9% | 35,280 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $785,000 | -5.6% | 35,280 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $832,000 | -64.3% | 35,280 | +23.9% | 0.00% | -62.5% |
| Q2 2015 | $2,329,000 | -11.7% | 28,480 | 0.0% | 0.01% | -11.1% |
| Q1 2015 | $2,637,000 | – | 28,480 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |